Hyun, Seung-Jae
(Department of Neurosurgery, Spine Center, Seoul National University Bundang Hospital, Seoul National University College of Medicine)
Yoon, Seung Hwan (Department of Neurosurgery, Inha University College of Medicine) Kim, Joo Han (Department of Neurosurgery, Korea University Guro Hospital, Korea University College of Medicine) Oh, Jae Keun (Department of Neurosurgery, Spine Center, Hallym University Sacred Heart Hospital) Lee, Chang-Hyun (Department of Neurosurgery, Seoul National University Hospital, Seoul National University College of Medicine) Shin, Jun Jae (Department of Neurosurgery, Yongin Severance Hospital, Spine and Spinal Cord Institute, Yonsei University College of Medicine) Kang, Jiin (Department of Neurosurgery, Yongin Severance Hospital, Spine and Spinal Cord Institute, Yonsei University College of Medicine) Ha, Yoon (Department of Neurosurgery, Spine and Spinal Cord Institute, Yonsei University College of Medicine) |
1 | Carragee EJ, Chu G, Rohatgi R, Hurwitz EL, Weiner BK, Yoon ST, et al. : Cancer risk after use of recombinant bone morphogenetic protein-2 for spinal arthrodesis. J Bone Joint Surg Am 95 : 1537-1545, 2013 DOI |
2 | Epstein NE : Basic science and spine literature document bone morphogenetic protein increases cancer risk. Surg Neurol Int 5(suppl 15) : S552-S560, 2014 |
3 | Guerado E, Fuerstenberg CH : What bone graft substitutes should we use in post-traumatic spinal fusion? Injury 42 Suppl 2 : S64-S71, 2011 DOI |
4 | Kim DJ : Autogenous bone graft and bone substitutes. J Korean Soc Spine Surg 15 : 54-65, 2008 DOI |
5 | Urist MR, Strates BS : Bone formation in implants of partially and wholly demineralized bone matrix. Including observations on acetone-fixed intra and extracellular proteins. Clin Orthop Relat Res 71 : 271-278, 1970 |
6 | Katayama Y, Matsuyama Y, Yoshihara H, Sakai Y, Nakamura H, Imagama S, et al. : Clinical and radiographic outcomes of posterolateral lumbar spine fusion in humans using recombinant human bone morphogenetic protein-2: an average five-year follow-up study. Int Orthop 33 : 1061-1067, 2009 DOI |
7 | Brantigan JW, Steffee AD, Geiger JM : A carbon fiber implant to aid interbody lumbar fusion. Mechanical testing. Spine (Phila Pa 1976) 16(6 Suppl) : S277-S282, 1991 DOI |
8 | Lad SP, Bagley JH, Karikari IO, Babu R, Ugiliweneza B, Kong M, et al. : Cancer after spinal fusion: the role of bone morphogenetic protein. Neurosurgery 73 : 440-449, 2013 DOI |
9 | Ma GW : Posterior lumbar interbody fusion with specialized instruments. Clin Orthop Relat Res (193) : 57-63, 1985 |
10 | Massaad E, Fatima N, Kiapour A, Hadzipasic M, Shankar GM, Shin JH : Polyetheretherketone versus titanium cages for posterior lumbar interbody fusion: meta-analysis and review of the literature. Neurospine 17 : 125-135, 2020 DOI |
11 | Yan L, Chang Z, He B, Liu T, Wang X, Guo H, et al. : Efficacy of rhBMP-2 versus iliac crest bone graft for posterior C1-C2 fusion in patients older than 60 years. Orthopedics 37 : e51-e57, 2014 DOI |
12 | Niederwanger M, Urist MR : Demineralized bone matrix supplied by bone banks for a carrier of recombinant human bone morphogenetic protein (rhBMP-2): a substitute for autogeneic bone grafts. J Oral Implantol 22 : 210-215, 1996 |
13 | May RD, Frauchiger DA, Albers CE, Hofstetter W, Gantenbein B : Exogenous stimulation of human intervertebral disc cells in 3-dimensional alginate bead culture with BMP2 and L51P: cytocompatibility and effects on cell phenotype. Neurospine 17 : 77-87, 2020 DOI |
14 | McKay WF, Peckham SM, Badura JM : A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE bone graft). Int Orthop 31 : 729-734, 2007 DOI |
15 | Mindea SA, Shih P, Song JK : Recombinant human bone morphogenetic protein-2-induced radiculitis in elective minimally invasive transforaminal lumbar interbody fusions: a series review. Spine (Phila Pa 1976) 34 : 1480-1484; discussion 1485, 2009 DOI |
16 | Schmidmaier G, Herrmann S, Green J, Weber T, Scharfenberger A, Haas NP, et al. : Quantitative assessment of growth factors in reaming aspirate, iliac crest, and platelet preparation. Bone 39 : 1156-1163, 2006 DOI |
17 | Overley SC, McAnany SJ, Anwar MA, Merrill RK, Lovy A, Guzman JZ, et al. : Predictive factors and rates of fusion in minimally invasive transforaminal lumbar interbody fusion utilizing rhBMP-2 or mesenchymal stem cells. Int J Spine Surg 13 : 46-52, 2019 DOI |
18 | Rihn JA, Patel R, Makda J, Hong J, Anderson DG, Vaccaro AR, et al. : Complications associated with single-level transforaminal lumbar interbody fusion. Spine J 9 : 623-629, 2009 DOI |
19 | Sampath TK, Maliakal JC, Hauschka PV, Jones WK, Sasak H, Tucker RF, et al. : Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J Biol Chem 267 : 20352-20362, 1992 DOI |
20 | Smucker JD, Rhee JM, Singh K, Yoon ST, Heller JG : Increased swelling complications associated with off-label usage of rhBMP-2 in the anterior cervical spine. Spine (Phila Pa 1976) 31 : 2813-2819, 2006 DOI |
21 | Takeda M : Experience in posterior lumbar interbody fusion: unicortical versus bicortical autologous grafts. Clin Orthop Relat Res (193) : 120-126, 1985 |
22 | Urist MR : Bone: formation by autoinduction. Science 150 : 893-899, 1965 DOI |
23 | Villavicencio AT, Burneikiene S, Nelson EL, Bulsara KR, Favors M, Thramann J : Safety of transforaminal lumbar interbody fusion and intervertebral recombinant human bone morphogenetic protein-2. J Neurosurg Spine 3 : 436-443, 2005 DOI |
24 | Winn SR, Uludag H, Hollinger JO : Carrier systems for bone morphogenetic proteins. Clin Orthop Relat Res (367 Suppl) : S95-S106, 1999 DOI |
25 | Boden SD, Kang J, Sandhu H, Heller JG : Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies. Spine (Phila Pa 1976) 27 : 2662-2673, 2002 DOI |
26 | Mummaneni PV, Pan J, Haid RW, Rodts GE : Contribution of recombinant human bone morphogenetic protein-2 to the rapid creation of interbody fusion when used in transforaminal lumbar interbody fusion: a preliminary report. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004. J Neurosurg Spine 1 : 19-23, 2004 DOI |
27 | Shahlaie K, Kim KD : Occipitocervical fusion using recombinant human bone morphogenetic protein-2: adverse effects due to tissue swelling and seroma. Spine (Phila Pa 1976) 33 : 2361-2366, 2008 DOI |
28 | Choudhry OJ, Christiano LD, Singh R, Golden BM, Liu JK : Bone morphogenetic protein-induced inflammatory cyst formation after lumbar fusion causing nerve root compression. J Neurosurg Spine 16 : 296-301, 2012 DOI |
29 | Chang HK, Huang M, Wu JC, Huang WC, Wang MY : Less opioid consumption with enhanced recovery after surgery transforaminal lumbar interbody fusion (TLIF): a comparison to standard minimally-invasive TLIF. Neurospine 17 : 228-236, 2020 DOI |
30 | Gruskin E, Doll BA, Futrell FW, Schmitz JP, Hollinger JO : Demineralized bone matrix in bone repair: history and use. Adv Drug Deliv Rev 64 : 1063-1077, 2012 DOI |
31 | Bormann N, Schwabe P, Smith MD, Wildemann B : Analysis of parameters influencing the release of antibiotics mixed with bone grafting material using a reliable mixing procedure. Bone 59 : 162-172, 2014 DOI |
32 | Brekke JH, Toth JM : Principles of tissue engineering applied to programmable osteogenesis. J Biomed Mater Res 43 : 380-398, 1998 DOI |
33 | Deutsch H : High-dose bone morphogenetic protein-induced ectopic abdomen bone growth. Spine J 10 : e1-e4, 2010 DOI |
34 | Burkus JK, Gornet MF, Dickman CA, Zdeblick TA : Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages. J Spinal Disord Tech 15 : 337-349, 2002 DOI |
35 | Chen NF, Smith ZA, Stiner E, Armin S, Sheikh H, Khoo LT : Symptomatic ectopic bone formation after off-label use of recombinant human bone morphogenetic protein-2 in transforaminal lumbar interbody fusion. J Neurosurg Spine 12 : 40-46, 2010 DOI |
36 | Cooper GS, Kou TD : Risk of cancer after lumbar fusion surgery with recombinant human bone morphogenic protein-2 (rh-BMP-2). Spine (Phila Pa 1976) 38 : 1862-1868, 2013 DOI |
37 | Gitelman SE, Kobrin MS, Ye JQ, Lopez AR, Lee A, Derynck R : Recombinant Vgr-1/BMP-6-expressing tumors induce fibrosis and endochondral bone formation in vivo. J Cell Biol 126 : 1595-1609, 1994 DOI |
38 | Han B, Yang Z, Nimni M : Effects of moisture and temperature on the osteoinductivity of demineralized bone matrix. J Orthop Res 23 : 855-861, 2005 DOI |
39 | Haws BE, Khechen B, Patel DV, Yoo JS, Guntin JA, Cardinal KL, et al. : Impact of iliac crest bone grafting on postoperative outcomes and complication rates following minimally invasive transforaminal lumbar interbody fusion. Neurospine 16 : 772-779, 2019 DOI |
![]() |